drugset / Trial / NCT00185068

An Examination of the Safety and Blood Pressure Lowering Effect of Increasing Doses of Benicar® and Benicar® HCT in Patients With Hypertension

NCT00185068

Phase 4 Completed 110 enrolled Daiichi Sankyo
Non-randomizedSingle-groupOpen-labelTreatment

Summary

Effect of increasing doses of olmesartan medoxomil and olmesartan medoxomil/hydrochlorothiazide on blood pressure in patients with hypertension

Timeline

Start
2004-03
Primary completion
Completion
2004-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Hydrochlorothiazide Unknown
Subject Olmesartan medoxomil Unknown

Indications